Exact Mass: 494.2026112

Exact Mass Matches: 494.2026112

Found 500 metabolites which its exact mass value is equals to given mass value 494.2026112, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Glaucarubinone

Butyric acid, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epoxymethano)phenanthro[10,1-bc]pyran-5,10(3H,6a.beta.H)-dione

C25H34O10 (494.2151864)

Glaucarubinone is a quassinoid with formula C25H34O10. It is a natural product isolated from several plant species and exhibits anti-cancer and anti-malarial properties. It has a role as a geroprotector, a plant metabolite, an antineoplastic agent and an antimalarial. It is a carboxylic ester, a quassinoid, an organic heteropentacyclic compound, a tetrol, a secondary alpha-hydroxy ketone and a tertiary alpha-hydroxy ketone. Glaucarubinone is a natural product found in Simarouba amara, Cunila, and other organisms with data available. A quassinoid with formula C25H34O10. It is a natural product isolated from several plant species and exhibits anti-cancer and anti-malarial properties.

Fluocinonide

2-[(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosa-14,17-dien-8-yl]-2-oxoethyl acetate

C26H32F2O7 (494.21159859999995)

Fluocinonide is only found in individuals that have used or taken this drug. It is a topical glucocorticoid used in the treatment of eczema. [PubChem]Fluocinonide is a potent glucocorticoid steroid used topically as anti-inflammatory agent for the treatment of skin disorders such as eczema. It relieves itching, redness, dryness, crusting, scaling, inflammation, and discomfort. Fluocinonide binds to the cytosolic glucocorticoid receptor. After binding the receptor the newly formed receptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes. The anti-inflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. Specifically glucocorticoids induce lipocortin-1 (annexin-1) synthesis, which then binds to cell membranes preventing the phospholipase A2 from coming into contact with its substrate arachidonic acid. This leads to diminished eicosanoid production. Cyclooxygenase (both COX-1 and COX-2) expression is also suppressed, potentiating the effect. In another words, the two main products in inflammation Prostaglandins and Leukotrienes are inhibited by the action of Glucocorticoids. Glucocorticoids also stimulate the lipocortin-1 escaping to the extracellular space, where it binds to the leukocyte membrane receptors and inhibits various inflammatory events: epithelial adhesion, emigration, chemotaxis, phagocytosis, respiratory burst and the release of various inflammatory mediators (lysosomal enzymes, cytokines, tissue plasminogen activator, chemokines etc.) from neutrophils, macrophages and mastocytes. Additionally the immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding. Like other glucocorticoid agents Fluocinolone acetonide acts as a physiological antagonist to insulin by decreasing glycogenesis (formation of glycogen). It also promotes the breakdown of lipids (lipolysis), and proteins, leading to the mobilization of extrahepatic amino acids and ketone bodies. This leads to increased circulating glucose concentrations (in the blood). There is also decreased glycogen formation in the liver. C - Cardiovascular system > C05 - Vasoprotectives > C05A - Agents for treatment of hemorrhoids and anal fissures for topical use > C05AA - Corticosteroids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents

Soularubinone

[(1S,4R,5R,6R,7S,8R,11R,13S,17S,18S,19R)-4,5,17-trihydroxy-6,14,18-trimethyl-9,16-dioxo-3,10-dioxapentacyclo[9.8.0.01,7.04,19.013,18]nonadec-14-en-8-yl] 3-hydroxy-3-methylbutanoate

C25H34O10 (494.2151864)

Amdro

hydramethylnon

C25H24F6N4 (494.19050559999994)

D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4856; ORIGINAL_PRECURSOR_SCAN_NO 4854 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4845; ORIGINAL_PRECURSOR_SCAN_NO 4843 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4858; ORIGINAL_PRECURSOR_SCAN_NO 4856 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4880; ORIGINAL_PRECURSOR_SCAN_NO 4878 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9324; ORIGINAL_PRECURSOR_SCAN_NO 9322 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9337; ORIGINAL_PRECURSOR_SCAN_NO 9336 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9290; ORIGINAL_PRECURSOR_SCAN_NO 9289 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4940; ORIGINAL_PRECURSOR_SCAN_NO 4938 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4851; ORIGINAL_PRECURSOR_SCAN_NO 4847 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9266; ORIGINAL_PRECURSOR_SCAN_NO 9265 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9299; ORIGINAL_PRECURSOR_SCAN_NO 9298 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9304; ORIGINAL_PRECURSOR_SCAN_NO 9303

nazartinib

C26H31ClN6O2 (494.2196896)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D000970 - Antineoplastic Agents

Gibberellin A4 glucosyl ester

(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1R,2R,5R,8R,9S,10R,11S,12S)-12-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.1^{5,8}.0^{1,10}.0^{2,8}]heptadecane-9-carboxylate

C25H34O10 (494.2151864)

Gibberellin A4 glucosyl ester (GA4 glucosyl ester) belongs to the class of organic compounds known as diterpene glycosides. These are diterpenoids in which an isoprene unit is glycosylated. Gibberellin A4 glucosyl ester is found in pulses. Gibberellin A4 glucosyl ester is a constituent of seeds of French bean (Phaseolus vulgaris). Constituent of seeds of French bean (Phaseolus vulgaris). Gibberellin A4 glucosyl ester is found in pulses, yellow wax bean, and green bean.

Gibberellin A20 13-glucoside

(1R,2R,5S,8S,9S,10R,11R)-11-methyl-6-methylidene-16-oxo-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-15-oxapentacyclo[9.3.2.1^{5,8}.0^{1,10}.0^{2,8}]heptadecane-9-carboxylic acid

C25H34O10 (494.2151864)

Gibberellin A20 13-glucoside (GA20 13-glucoside) belongs to the class of organic compounds known as diterpene glycosides. These are diterpenoids in which an isoprene unit is glycosylated. Gibberellin A20 13-glucoside is found in cereals and cereal products. Gibberellin A20 13-glucoside is a constituent of barley Hordeum vulgare. Constituent of barley Hordeum vulgare. Gibberellin A20 13-glucoside is found in barley and cereals and cereal products. Gibbane-1,10-dicarboxylic acid, 7-(β-D-glucopyranosyloxy)-4a-hydroxy-1-methyl-8-methylene-, 1,4a-lactone, (1α,4aα,4bβ,10β)-. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=73607-09-7 (retrieved 2024-08-12) (CAS RN: 73607-09-7). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

(8S,8'S)-Secoisolariciresinol 9-xyloside

2-{4-hydroxy-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butoxy}oxane-3,4,5-triol

C25H34O10 (494.2151864)

(8S,8S)-Secoisolariciresinol 9-xyloside is found in herbs and spices. (8S,8S)-Secoisolariciresinol 9-xyloside is a constituent of Laurus nobilis (bay laurel). Constituent of Laurus nobilis (bay laurel). (8S,8S)-Secoisolariciresinol 9-xyloside is found in tea and herbs and spices.

3,6,9,12-Tetraazatetradecanedioic acid, 3,6,9,12-tetrakis(carboxymethyl)-

C18H30N4O12 (494.186014)

D064449 - Sequestering Agents > D002614 - Chelating Agents

Balapiravir

[2-Azido-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)-3,4-bis[(2-methylpropanoyl)oxy]oxolan-2-yl]methyl 2-methylpropanoic acid

C21H30N6O8 (494.212502)

Diflorasone diacetate

[2-(17-Acetyloxy-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl)-2-oxoethyl] acetate

C26H32F2O7 (494.21159859999995)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids D000893 - Anti-Inflammatory Agents

1-(1H-Imidazole-4-ylmethyl)-3-[2-[4-(2-methyl-3-chlorophenyl)piperazino]ethyl]-5,6-dimethoxy-1H-indazole

3-(2-(4-(3-Chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate

C26H31ClN6O2 (494.2196896)

Fluocinolone acetonide 21-acetate

2-{12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-8-yl}-2-oxoethyl acetate

C26H32F2O7 (494.21159859999995)

14-Methoxytajixanthone-25-acetate

(-)-14-Methoxytajixanthone-25-acetate

C28H30O8 (494.194058)

1-Homoacevaltrate

C25H34O10 (494.2151864)

Neohelmanthicin D

C25H34O10 (494.2151864)

1-Homoisoacevaltrate

C25H34O10 (494.2151864)

Forbesionic acid

C28H30O8 (494.194058)

Isoforbesionic acid

C28H30O8 (494.194058)

(2R,3R,4S,5S,6R)-2-[(3R)-1,7-bis(3,4-dihydroxyphenyl)heptan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

C25H34O10 (494.2151864)

indaquassin D

C25H34O10 (494.2151864)

C25H34O10

C25H34O10 (494.2151864)

(3R,5R)-3,5-Dihydroxy-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)heptane 3-O-??-D-glucopyranoside

C25H34O10 (494.2151864)

(2E,6R)-2,6-dimethyl-8-hydroxy-2-octenoic acid 8-O-[6-O-(E)-p-coumaroyl]-beta-D-glucopyranoside|(2E,6R)-2,6-Dimethyl-8-hydroxy-2-octenoic acid 8-O-[6-O-(E)-p-coumaroyl]-??-D-glucopyranoside

C25H34O10 (494.2151864)

dictazoline E

C27H26N8O2 (494.2178616)

3-acetyl-lemmonin A

C25H34O10 (494.2151864)

9alpha-isobutyryloxy-4beta,15-epoxyrepandanolide-8-O-(5-hydroxyangelate)|9alpha-isobutyryloxy-4beta,15-epoxyrepandanolide-8-O-<5-hydroxyangelate>

C25H34O10 (494.2151864)

patriscabroside III

C21H34O13 (494.1999314)

(3R,5R)-3,5-Dihydroxy-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)heptane 5-O-??-D-glucopyranoside

C25H34O10 (494.2151864)

SCHEMBL14823075

C26H35ClO7 (494.20711900000003)

Diversoside

7-[(E)-7-hydroxy-3,7-dimethyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoct-2-enoxy]chromen-2-one

C25H34O10 (494.2151864)

Picrasidine C

C29H26N4O4 (494.19539560000004)

altissinol B

C25H34O10 (494.2151864)

metatacarboline G

C26H30N4O6 (494.216524)

7-O-Acetylneocaesalpin N

C25H34O10 (494.2151864)

ligraminol E 4-O-beta-D-xyloside

C25H34O10 (494.2151864)

cambodianin H

C28H30O8 (494.194058)

caeruleanone B

C28H30O8 (494.194058)

Phyllaemblicin D

C21H34O13 (494.1999314)

pituranthoside

C25H34O10 (494.2151864)

Tetraludin L|Tetraludin M

C25H34O10 (494.2151864)

spirocaesalmin

C25H34O10 (494.2151864)

6alpha-tigloyloxyglaucarubol

C25H34O10 (494.2151864)

C27H30N2O7

C27H30N2O7 (494.205291)

2-(4-hydroxyphenyl)ethyl 4,6-O-[(1R,4E)-3-(2-ethoxy-2-oxoethyl)-4-formylhex-4-en-1-ylidene]-beta-Dglucopyranoside|ilexin A

C25H34O10 (494.2151864)

C22H38O10S

C22H38O10S (494.2185568)

(-)-secoisolariciresinol 9-O-beta-D-xylopyranoside

C25H34O10 (494.2151864)

3-N-formylstaurosporine|N-formyl-staurosporine

C29H26N4O4 (494.19539560000004)

Ser Gly Ala Asn Phe

C21H30N6O8 (494.212502)

(E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)octan-1-imine

C19H34N4O7S2 (494.1868814)

FLUOCINONIDE

C26H32F2O7 (494.21159859999995)

C - Cardiovascular system > C05 - Vasoprotectives > C05A - Agents for treatment of hemorrhoids and anal fissures for topical use > C05AA - Corticosteroids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents

MLS001333220-01!FLUOCINONIDE356-12-7

C26H32F2O7 (494.21159859999995)

MLS001076548-01!

C26H32F2O7 (494.21159859999995)

(2R,3R,4S,5S,6R)-2-[(3R)-1,7-bis(3,4-dihydroxyphenyl)heptan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

NCGC00169998-02!(2R,3R,4S,5S,6R)-2-[(3R)-1,7-bis(3,4-dihydroxyphenyl)heptan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

C25H34O10 (494.2151864)

rubranoside A

(3R)-1,7-Bis(3,4-dihydroxyphenyl)-3-heptanyl ?-D-glucopyranoside

C25H34O10 (494.2151864)

(2R,3R,4S,5S,6R)-2-[(3R)-1,7-bis(3,4-dihydroxyphenyl)heptan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol_major

C25H34O10 (494.2151864)

hydramethylnon

Pesticide8_Hydramethylnon_C25H24F6N4_2(1H)-Pyrimidinone, tetrahydro-5,5-dimethyl-, 2-[(2E)-3-[4-(trifluoromethyl)phenyl]-1-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-2-propen-1-ylidene]hydrazone

C25H24F6N4 (494.19050559999994)

Ala Glu Glu Phe

(4S)-4-[(2S)-2-[(2S)-2-aminopropanamido]-4-carboxybutanamido]-4-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butanoic acid

C22H30N4O9 (494.201269)

Ala Glu Phe Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carboxybutanamido]-3-phenylpropanamido]pentanedioic acid

C22H30N4O9 (494.201269)

Ala Phe Glu Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-4-carboxybutanamido]pentanedioic acid

C22H30N4O9 (494.201269)

Ala His His Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C20H30N8O5S (494.205977)

Ala His Met His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H30N8O5S (494.205977)

Ala Met His His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H30N8O5S (494.205977)

Ala Asn Gln Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanoic acid

C21H30N6O8 (494.212502)

Ala Asn Tyr Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanoic acid

C21H30N6O8 (494.212502)

Ala Gln Asn Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C21H30N6O8 (494.212502)

Ala Gln Tyr Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanoic acid

C21H30N6O8 (494.212502)

Ala Tyr Asn Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]-4-carbamoylbutanoic acid

C21H30N6O8 (494.212502)

Ala Tyr Gln Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanamido]-3-carbamoylpropanoic acid

C21H30N6O8 (494.212502)

Cys Glu Ile Met

(4S)-4-[(2R)-2-amino-3-sulfanylpropanamido]-4-{[(1S,2S)-1-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}-2-methylbutyl]carbamoyl}butanoic acid

C19H34N4O7S2 (494.1868814)

Cys Glu Leu Met

(4S)-4-[(2R)-2-amino-3-sulfanylpropanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}-3-methylbutyl]carbamoyl}butanoic acid

C19H34N4O7S2 (494.1868814)

Cys Glu Met Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carboxybutanamido]-4-(methylsulfanyl)butanamido]-3-methylpentanoic acid

C19H34N4O7S2 (494.1868814)

Cys Glu Met Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carboxybutanamido]-4-(methylsulfanyl)butanamido]-4-methylpentanoic acid

C19H34N4O7S2 (494.1868814)

Cys His His Val

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

C20H30N8O5S (494.205977)

Cys His Val His

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H30N8O5S (494.205977)

Cys Ile Glu Met

(4S)-4-[(2S,3S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylpentanamido]-4-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C19H34N4O7S2 (494.1868814)

Cys Ile Met Glu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylpentanamido]-4-(methylsulfanyl)butanamido]pentanedioic acid

C19H34N4O7S2 (494.1868814)

Cys Ile Pro Tyr

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanoic acid